Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (81-90 of 236) with videos related to

Pageof 24
Sort By:
American Journal of Diseases of Children (1960)|December 1, 1983
Pharmacodynamics and kinetics of cimetidine in a premature newbornJ V Aranda, E W Outerbridge, J J Schentag
Antimicrobial Agents and Chemotherapy|May 1, 1982
Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsJ J Schentag, F B Cerra, M E Plaut
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|December 1, 1990
Pharmacokinetics of lomefloxacin in renally compromised patientsR A Blum, R W Schultz, J J Schentag
Antimicrobial Agents and Chemotherapy|May 1, 1981
Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patientsJ J Schentag, M E Plaut, F B Cerra
Annals of Surgery|May 1, 1981
Effect of bile induced pancreatitis on tobramycin excretion in pancreatic fluidJ G Studley, J J Schentag, W G Schenk
Clinical Chemistry|February 1, 1981
Liquid-chromatographic determination of cimetidine, its known metabolites, and creatinine in serum and urineJ A Ziemniak, D A Chiarmonte, J J Schentag
DICP : the Annals of Pharmacotherapy|October 1, 1991
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman
DICP : the Annals of Pharmacotherapy|October 1, 1989
Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patientsJ J Schentag, C A Carter, L S Welage
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
What have we learned from pharmacokinetic and pharmacodynamic theories?J J Schentag, K K Gilliland, J A Paladino
Pageof 24

Showing results (81-90 of 236) with videos related to

Sort By:
Pageof 24
American Journal of Diseases of Children (1960)|December 1, 1983
Pharmacodynamics and kinetics of cimetidine in a premature newbornJ V Aranda, E W Outerbridge, J J Schentag
Antimicrobial Agents and Chemotherapy|May 1, 1982
Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsJ J Schentag, F B Cerra, M E Plaut
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|December 1, 1990
Pharmacokinetics of lomefloxacin in renally compromised patientsR A Blum, R W Schultz, J J Schentag
Antimicrobial Agents and Chemotherapy|May 1, 1981
Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patientsJ J Schentag, M E Plaut, F B Cerra
Annals of Surgery|May 1, 1981
Effect of bile induced pancreatitis on tobramycin excretion in pancreatic fluidJ G Studley, J J Schentag, W G Schenk
Clinical Chemistry|February 1, 1981
Liquid-chromatographic determination of cimetidine, its known metabolites, and creatinine in serum and urineJ A Ziemniak, D A Chiarmonte, J J Schentag
DICP : the Annals of Pharmacotherapy|October 1, 1991
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman
DICP : the Annals of Pharmacotherapy|October 1, 1989
Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patientsJ J Schentag, C A Carter, L S Welage
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
What have we learned from pharmacokinetic and pharmacodynamic theories?J J Schentag, K K Gilliland, J A Paladino
Pageof 24